Literature DB >> 1460684

Time-related effects of heparin sulfate on regional and systemic anticoagulation.

C K Vincent1, T W Wakefield, B Lindblad, J C Stanley, A W Fleming.   

Abstract

Optimal timing of vascular clamping to anticoagulation during cardiovascular surgical procedures is poorly defined. This study uses a canine model to determine the effectiveness of three different methods of heparin administration. Heparin sulfate (150 IU/kg) was administered by: injection into the jugular vein 5 minutes before infrarenal aortic clamping (Group 1), injection into the terminal aorta immediately after infrarenal aortic clamping (Group 2), and injection into the jugular vein immediately after infrarenal aortic clamping (Group 3). Thrombin clotting times and partial thromboplastin times were measured in venous blood from the upper and lower extremities before (baseline) heparin administration, and 1, 3, and 5 minutes following heparin administration. Activated clotting times were assessed in lower extremity blood at baseline, and at 1 and 5 minutes after heparin injection. Significant differences existed between groups in both upper and lower extremities. Systemic anticoagulation occurred within 1 minute after intravenous heparin administration in Groups 1 and 2 in the lower extremity, and Groups 1 and 3 in the upper extremity. Delayed anticoagulation in the lower extremity was noted with systemic injection after aortic clamping in Group 3, and after regional intra-aortic administration in the upper extremity of Group 2 subjects. Complete anticoagulation was noted by 5 minutes in all groups in both the upper and lower extremities. These results suggest that the safe time period between heparin administration and vascular clamping varies with the route and the timing of its administration. Intravenous administration prior to aortic cross-clamping provided adequate anticoagulation in this canine model in both the upper and lower extremity blood after 1 minute of heparin circulation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1460684      PMCID: PMC2571734     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  10 in total

1.  Monitoring of intraoperative heparinization in vascular surgery.

Authors:  J Manny; H Romanoff; E Hyam; N Manny
Journal:  Surgery       Date:  1976-11       Impact factor: 3.982

2.  Pharmacokinetic modeling of heparin and its clinical implications.

Authors:  T J McAvoy
Journal:  J Pharmacokinet Biopharm       Date:  1979-08

3.  Heparin levels and activated clotting time (ACT) during open heart surgery.

Authors:  S Stenbjerg; E Berg; O K Albrechtsen
Journal:  Scand J Haematol       Date:  1981-04

4.  Laboratory monitoring of heparin. Effect of reagents and instruments on the activated partial thromboplastin time.

Authors:  J T Brandt; D A Triplett
Journal:  Am J Clin Pathol       Date:  1981-10       Impact factor: 2.493

5.  Kinetics of heparin administration.

Authors:  M O Perry; J Horton
Journal:  Arch Surg       Date:  1976-04

6.  Heparin kinetics in venous thrombosis and pulmonary embolism.

Authors:  J Hirsh; W G van Aken; A S Gallus; C T Dollery; J F Cade; W L Yung
Journal:  Circulation       Date:  1976-04       Impact factor: 29.690

7.  Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage.

Authors:  B S Bull; W M Huse; F S Brauer; R A Korpman
Journal:  J Thorac Cardiovasc Surg       Date:  1975-05       Impact factor: 5.209

8.  Clinical experience with the activated clotting time for the control of heparin and protamine therapy during cardiopulmonary bypass.

Authors:  B F Akl; G M Vargas; J Neal; J Robillard; P Kelly
Journal:  J Thorac Cardiovasc Surg       Date:  1980-01       Impact factor: 5.209

9.  Intraoperative anticoagulation in cardiovascular surgery.

Authors:  D J Effeney; J Goldstone; D Chin; W C Krupski; R J Ellis
Journal:  Surgery       Date:  1981-12       Impact factor: 3.982

10.  Heparin dose for accurate anticoagulation in cardiac surgery.

Authors:  D B Doty; H W Knott; J L Hoyt; J A Koepke
Journal:  J Cardiovasc Surg (Torino)       Date:  1979 Nov-Dec       Impact factor: 1.888

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.